Cabaletta Bio is trading 5.19% down now at $3.29 after a broad risk-off session marked by rising oil prices, Middle East tensions, and weaker major indexes.
- The Dow is down 1.00%, while the S&P 500 and Nasdaq are also lower, supporting a global-market explanation.
- Investor meetings are scheduled for September 8, 2026.
- No new company-specific negative announcement was identified.